Avalyn Pharma Inc. (NASDAQ:AVLN – Get Free Report) Director Jill Carroll purchased 277,778 shares of Avalyn Pharma stock in a transaction on Friday, May 1st. The stock was bought at an average price of $18.00 per share, with a total value of $5,000,004.00. Following the transaction, the director owned 2,186,562 shares of the company’s stock, valued at approximately $39,358,116. This represents a 14.55% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Avalyn Pharma Stock Performance
AVLN traded up $0.35 during midday trading on Friday, reaching $29.84. The company had a trading volume of 830,048 shares. Avalyn Pharma Inc. has a 1 year low of $26.00 and a 1 year high of $30.20.
Featured Stories
Receive News & Ratings for Avalyn Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalyn Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
